Proximity to the US-Mexico border: A key to explaining geographic variation in US methamphetamine, cocaine and heroin purity

Addiction

Volumn 105, Issue 10, 2010, Pages 1785-1798

  Cunningham, James K ^a   Maxwell, Jane Carlisle ^b   Campollo, Octavio ^c   Cunningham, Kathryn I ^d   Liu, Lon Mu ^e   Lin, Hui Lin ^e  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

^d University of Arizona   (United States)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Cocaine; drug purity; geographic variance; heroin; methamphetamine; US Mexico border

Indexed keywords

COCAINE; DIAMORPHINE; METHAMPHETAMINE;

ARTICLE; CHEMISTRY; COMMERCIAL PHENOMENA; DRUG CONTAMINATION; DRUG CONTROL; DRUG FORMULATION; HUMAN; INFORMATION RETRIEVAL; LEGAL ASPECT; MEXICO; STATISTICAL ANALYSIS; STATISTICAL MODEL; STATISTICS; TIME; UNITED STATES;

COCAINE; COMMERCE; DATA INTERPRETATION, STATISTICAL; DRUG AND NARCOTIC CONTROL; DRUG COMPOUNDING; DRUG CONTAMINATION; HEROIN; HUMANS; INFORMATION STORAGE AND RETRIEVAL; LINEAR MODELS; METHAMPHETAMINE; MEXICO; MODELS, STATISTICAL; TIME FACTORS; UNITED STATES;

EID: 77956735045     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2010.03032.x     Document Type: Article

References (70)

1. Darke S., Hall W., Weatherburn D., Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend 1999 54 : 155 161.
2. Darke S., Hall W. Heroin overdose: research and evidence-based intervention. J Urban Health 2003 80 : 189 200.
3. Cunningham J. K., Liu L.-M. Impacts of federal ephedrine and pseudoephedrine regulations on methamphetamine-related hospital admissions. Addiction 2003 98 : 1229 1237.
4. Cunningham J. K., Liu L.-M., Callaghan R. Impact of US and Canadian precursor regulation on methamphetamine purity in the United States. Addiction 2009 104 : 441 453.
5. Mittleman R. E., Wetli C. V. Death caused by recreational cocaine use. JAMA 1984 252 : 1889 1893.
6. Hopfer C. J., Mikulich S. K., Crowley T. J. Heroin use among adolescents in treatment for substance use disorders. J Am Acad Child Adolesc Psychiatry 2000 39 : 1316 1323.
7. Hopfer C. J., Khuri E., Crowley T. J., Hooks S. Adolescent heroin use: a review of the descriptive and treatment literature. J Subst Abuse Treat 2002 23 : 231 237.
8. Tarabar A. F., Nelson L. S. The resurgence and abuse of heroin by children in the United States. Curr Opin Pediatr 2003 15 : 210 215.
9. Cho A. K. Ice: a new dosage form of an old drug. Science 1990 249 : 631 634.
10. Cook C. E., Jeffcoat A. R., Hill J. M., Pugh D. E., Patetta P. K., Sadler B. M. et al. Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 1993 21 : 717 723.
11. McKetin R., Kelly E., McLaren J. The relationship between crystalline methamphetamine use and methamphetamine dependence. Drug Alcohol Depend 2006 85 : 198 204.
12. Cunningham J. K., Liu L.-M., Muramoto M. Methamphetamine suppression and route of administration: precursor regulation impacts on snorting, smoking, swallowing and injecting. Addiction 2008 103 : 1174 1186.
13. Brugal M. T., Barrio G., de la Fuente L., Regidor E., Royuela L., Suelves J. M. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002 97 : 319 327.
14. De la Fuente L., Saavedra P., Barrio G., Royuela L., Vicente J. Temporal and geographic variations in the characteristics of heroin seized in Spain and their relation with the route of administration. Spanish Group for the Study of the Purity of Seized Drugs. Drug Alcohol Depend 1996 40 : 185 194.
15. Brugal M. T., Barrio G., Regidor E., Mestres M., Cayla J. A., de la Fuente L. Discrepancias en el número de muertes por reacción aguda a sustancias psicoactivas registradas en España Discrepancies in the number of deaths from acute reaction to psychoactive substances recorded in Spain. Gaceta Sanitaria 1999 13 : 82 7.
16. Delegación del Gobierno para el Plan Nacional sobre Drogas. Informe No. 3. Observatorio Español sobre Drogas, Marzo 2000 Government Delegation for the National Plan on Drugs. Report 3. Spanish Drug Observatory, March 2000 Madrid : Ministerio del Interior 2000.
17. Pfeiffer D. U., Robinson T., Stevenson M., Stevens K. B., Rogers D. J., Clements A. C. A. Spatial Analysis in Epidemiology. New York : Oxford University Press 2008.
18. Dummer T. J. B. Health geography: supporting public health policy and planning. Can Med Assoc J 2008 178 : 1177 1180.
19. Tunstall H. V. Z., Shaw M., Dorling D. Places and health. J Epidemiol Commun Health 2004 58 : 6 10.
20. Kearns R., Moon G. From medical to health geography: novelty, place and theory after a decade of change. Prog Hum Geogr 2002 26 : 605 625.
21. Thomas Y. F., Richardson D., Cheung I. Integrating geography and social epidemiology in drug abuse. In : Thomas Y. F., Richardson D., Cheung I., editors. Geography and Drug Addiction. Berlin : Springer-Verlag 2008, p. 17 26.
22. McLafferty S. Placing Substance Abuse. In : Thomas Y. F., Richardson D., Cheung I., editors. Geography and Drug Addiction. Berlin : Springer-Verlag 2008, p. 1 16.
23. Drug Enforcement Administration. Drugs of Abuse. Washington, DC : US Department of Justice 2005.
24. Drug Enforcement Administration. Heroin. Domestic Monitor Program2006. Washington, DC : US Department of Justice 2007.
25. Drug Enforcement Administration. Heroin. Domestic Monitor Program Washington 2007. Washington, DC : US Department of Justice 2008.
26. Division of Epidemiology, Services and Prevention Research. Epidemiologic Trends in Drug Abuse. Proceedings of the Community Epidemiology Work Group, vol. II. Bethesda, MD : National Institute on Drug Abuse 2008.
27. Office of National Drug Control Policy. The Price and Purity of Illicit Drugs: 1981 through the Second Quarter of 2003. Washington, DC : Executive Office of the President of the United States 2004.
28. Fries A., Anthony R. W., Cseko A., Gaither C. C., Schulman E. The Price and Purity of Illicit Drugs: 1981-2007. Alexandria, VA : Institute for Defense Analyses 2008.
29. Redlinger L. J. Dealing in Dope: Market Mechanisms and Distribution Patterns of Illicit Narcotics. Ann Arbor, MI : University Microfilms, Inc. 1970.
30. Brown G. F., Silverman L. The retail price of heroin: estimation and applications. J Am Stat Assoc 1974 69 : 595 606.
31. Caulkins J., Padman R. Quantity discounts and quality premia for illicit drugs. J Am Stat Assoc 1993 88 : 748 757.
32. National Narcotics Intelligence Consumers Committee (NNICC). The NNICC Report 1996: The Supply of Illicit Drugs to the United States. Washington, DC : Drug Enforcement Administration 1996.
33. National Drug Intelligence Center. National Drug Threat Assessment 2005. Johnstown, PA : US Department of Justice 2005.
34. Constantine T. A. Statement by Thomas A. Constantine, Administrator, Drug Enforcement Administration, United Sates Department of Justice. Before the Senate Committee on Banking, Housing and Urban Affairs, Regarding Drug Trafficking in Mexico. Washington, DC : Drug Enforcement Administration 1996.
35. National Drug Intelligence Center. National Drug Threat Assessment 2008. Johnstown, PA : US Department of Justice 2007.
36. Wankel H. D. Statement by Harold D. Wankel, Chief of Operations, Drug Enforcement Administration, United States Department of Justice. Before the House Judiciary Committee, Regarding Drug Control Along the Southwest Border. Washington, DC : Drug Enforcement Administration 1996.
37. Constantine T. A. Statement by Thomas A. Constantine, Administrator, Drug Enforcement Administration, United States Department of Justice. Before the House Subcommittee on National Security, International Affairs and Criminal Justice. Regarding the Threat of Heroin to the United States. Washington, DC : Drug Enforcement Administration 1996.
38. Bucardo J., Brouwer K. C., Magis-Rodríguez C., Ramos R., Fraga M., Perez S. G. et al. Historical trends in the production and consumption of illicit drugs in Mexico: implications for the prevention of blood borne infections. Drug Alcohol Depend 2005 79 : 281 293.
39. Milford J. Statement by James Milford, Acting Deputy Administrator, Drug Enforcement Administration. Before the Subcommittee on National Security, International Affairs and Criminal Justice. Regarding Caribbean/South Florida. Washington, DC : Drug Enforcement Administration 1997.
40. National Drug Intelligence Center. Florida Drug Threat Assessment. Johnstown, PA : US Department of Justice 2003.
41. Intelligence Division. The Availability of Southwest Asian Heroin in the United States. Washington DC : Drug Enforcement Administration 1996.
42. Intelligence Division. Drug Intelligence Brief. Southeast Asian Heroin in the United States: DEA Indicator Programs Signal Reduced Availability. Washington, DC : Drug Enforcement Administration 2008.
43. Coomber R. The cutting of heroin in the United States in the 1990s. J Drug Issues 1999 29 : 17 36.
44. Arc View-2828-ESRI. ArcView. Redlands, CA : ESRI 2008.
45. Payan T. Three U.S.-Mexico Border Wars: Drugs, Immigration, and Homeland Security. Westport, CT : Praeger 2006.
46. von Hippel P. T. Normalization. In : Lewis-Beck M. S., Bryman A., Liao T. F., editors. Encyclopedia of Social Science Research Methods. Thousand Oaks, CA : Sage 2004, p. 746 747.
47. Cunningham J. K., Liu L.-M. Impacts of federal precursor chemical regulations on methamphetamine arrests. Addiction 2005 100 : 479 488.
48. Cunningham J. K., Liu L.-M. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment. Soc Sci Med 2008 66 : 1463 1473.
49. Raudenbush S. W., Bryk A. S. Hierarchical Linear Models: Applications and Data Analysis Methods, 2nd edn. Thousand Oaks, CA : Sage Publications 2002.
50. Tobler W. A computer model simulation of urban growth in the Detroit region. Econ Geogr 1970 46 : 234 240.
51. Rengert G. F., Lockwood B. Geographical units of analysis and the analysis of crime. In : Weisburd D. et al., editor. Putting Crime in Its Place. New York : Springer Science+Business Media, LLC 2009.
52. Cohen J., Cohen P., West S. G., Aiken L. S. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences, 3rd edn. Mahwah, NJ : Lawrence Erlbaum Associates 2003.
53. Kreft I. The effects of centering in multilevel analysis: is the public school the loser or the winner? A new analysis of an old question. Multilevel Modelling Newsletter 1995 7 : 5 8.
54. Criminal Intelligence Directorate. Drug Situation in Canada - 2003. Ottawa, ON : Royal Canadian Mounted Police 2004.
55. Criminal Intelligence Directorate. Drug Situation in Canada - 2004. Ottawa, ON : Royal Canadian Mounted Police 2005.
56. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS), 1992-2007. Concatenated Data Computer File. Ann Arbor, MI : Inter-university Consortium for Political and Social Research 2008.
57. Richard K. Emerging Trends in Drug Seizures - Information from the Drug Analysis Service (DAS). Ottawa, ON : Health Canada 2008.
58. Walker W. J. Statement of William J. Walker, Associate Special Agent in Charge, New York Field Division, Drug Enforcement Administration, Before the House Committee on Government Reform, Subcommittee on Criminal Justice, Drug Policy, and Human Resources & Select Committee on Homeland Security, Subcommittee on Homeland Security, Subcommittee on Infrastructure and Border Security. May 19, 2003. Washington, DC : Drug Enforcement Administration 2003.
59. National Drug Intelligence Center. National Drug Threat Assessment 2004. Johnstown, PA : US Department of Justice 2004.
60. Bureau of International Narcotics and Law Enforcement Affairs. International Narcotics Control Strategy Report: Canada, Mexico, and Central America. Washington, DC : US Department of State 2008.
61. Kenney M. The architecture of drug trafficking: network forms of organisation in the Columbian cocaine trade. Global Crime 2007 8 : 233 259.
62. Constantine T. A. Statement by Thomas A. Constantine, Administrator, Drug Enforcement Administration, United States Department of Justice, for Subcommittee on Crime and Criminal Justice, U. S. House of Representatives. Concerning Heroin Production and Trafficking Trends. September 29, 1994. Washington, DC : Drug Enforcement Administration 1994.
63. Intelligence Division. Drug Intelligence Brief. Heroin Signature Program: 2006. Washington, DC : Drug Enforcement Administration 2008.
64. Grassley C. E. Review of the Drug Enforcement Administration's Heroin Signature and Domestic Monitor Programs. Washington, DC : United States General Accounting Office 2001.
65. Cazenavette G. J. Statement by George J. Cazenavette, III, Special Agent in Charge, New Orleans Field Division, Drug Enforcement Administration, before the House Judiciary Subcommittee on Crime. February 25, 2000. Washington, DC : Drug Enforcement Administration 2000.
66. Drug Enforcement Administration. DEA Busts Georgia's First Meth 'Super-Lab'. Washington, DC : US Department of Justice 2005.
67. Preble E., Casey J. J. Taking care of business - the heroin user's life on the street. Int J Addict 1969 4 : 1 24.
68. Office of National Drug Control Policy. The Price of Illicit Drugs: 1981 through the Second Quarter of 2000. Washington, DC : Executive Office of the President of the United States 2001.
69. McKetin R., McLaren J., Kelley E., Chalmers J. The market for crystalline methamphetamine in Sydney, Australia. Global Crime 2009 10 : 113 123.
70. Robinson W. S. Ecological correlations and the behavior of individuals. Am Soc Rev 1950 15 : 351 357.